Dr Sharon Cohen joined touchNEUROLOGY in an interview published online on 27 April, to discuss the challenges in diagnosing Alzheimer’s disease (AD) at an early stage, the most exciting recent developments in diagnostic criteria, genetic testing, and neuroimaging techniques. Dr Cohen also talked through the recent developments in biomarker strategies for diagnosis and precision management of early AD. The presentation, entitled: "Accelerating Progress in Alzheimer’s Treatment. How Can we achieve timely, accurate, neuropathological diagnosis and precision management in early AD?" was presented at the International Conference of Alzheimer’s and Parkinson’s diseases and related neurological disorders (AD/PD). You can view the full interview, here: https://touchneurology.com/alzheimers-disease-dementia/conference-hub/sharon-cohen-ad-pd-2022-achieving-timely-accurate-neuropathological-diagnosis-and-precision-management-in-early-alzheimers-disease/
